Nebenwirkungen · Teysuno
Teysuno 15 mg/4.35 mg/11.8 mg hard capsules · Abschnitt 4.8 · PDF-Seite 18
HOS-123741 · Präparat HOS-095721
Terms for treatment-related ocular toxicities have been combined as follows. The only Grade 3 or higher adverse reaction was reduced visual acuity. • Vision disorder includes adverse reactions of blurred vision, diplopia, photopsia, reduced visual acuity, and blindness; • Lacrimal disorder includes adverse reactions of increased lacrimation, dry eye, and acquired dacryostenosis; • Eye disorder includes adverse reactions of eye pruritus, ocular hyperaemia, eye irritation, eye disorder, and foreign body sensation in eyes.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-30T14:44:00Z · SHA-256 d9fd4d001c3fc80cad8997ad588ff4e933bbc1b0d72de30b71e72b1dd2b35ec9 · Passage 9ec86bfa17ce915c933bf5163c2f640f932332a1c15b9cf44108fbecbf8bffc4 · Zeichen 15486–16020 im Abschnitt